GYN Flashcards
Women age <30
U/L, solitary, painless, firm, mobile mass
DOESN’T change w/ menstrual cycle
Can get increased pain or size prior to menses
Fibroadenoma
Women age 20-50
Multinodular breasts
B/L painful breast lumps
vary w/ menstrual cycle
Fibrocystic Disease
H/o recent trauma or surgery
fixed mass w/ skin or nipple retraction
mass solid on U/S
calcification on mammogram
Fat necrosis
DX and TX of Fat Necrosis
DX: Fine needle bx (shows foamy macrophages and fat globules)
TX: nothing just routine f/u
Causes of B/L nipple d/c
Prolactinoma
Hyperprolactinemia from MDXs
Hypothyroidism
Pregnancy
U/L, nonbloody nipple d/c
Intraductal Papilloma
U/L bloody nipple d/c
Breast Malignancy
Tx for Fibrocystic Disease
OCPs
Tx for Fibroadenoma
Reassurance in adolescents
In women ≥30 yoa –> Mammogram +/- U/S, followed by core bx if suspicious for malignancy
In women <30 yoa –> U/S +/- mammogram
- simple cyst = needle aspiration (if pt desires) - complex cyst/solid mass = image guided core bx
What to do if cyst aspirate is clear and cyst disappears after FNA?
Repeat breast exam and U/S in 4-6 wks
Tx for Lobar CA In Situ (LCIS)
tamoxifen x 5yrs
Tx for Ductal CA In Situ (DCIS)
lumpectomy + radiation + tamoxifen x 5 yrs
Tamoxifen MOA
Selective ER Modifier (SERM)
Breast ER receptor antagonist
Endometrial agonist
Bone agonist
SEs of Tamoxifen Use
Endometrial CA
Thromboembolism
Decreased osteoporosis
Hot flashes
NOTE: tamoxifen or raloxifene must be stopped 4 wks before major surgery to prevent DVTs
MDX to PREVENT breast cancer in pts w/ ≥ 2 first degree relatives w/ breast CA
Tamoxifen
TX for PREmenopausal woman w/ PR and ER (+) Cancer
Tamoxifen
TX for POSTmenopausal woman w/ PR and ER (+) Cancer
Aromatase inh. (eg. anastrozole) OR Tamoxifen
Aromatase Inh. MOA
Pure breast estrogen antagonists
bone antagonist
SEs of Aromatase Inh. Use
Increased osteoporosis
NO increased DVT risk
Monoclonal Ab against HER-2/NEU
Trastuzumab
Used in metastatic disease w/ over-expression of HER/NEU
SEs of Trastuzumab
Risk of cardiotoxicity w/ ↓ EF (do ECHO before starting MDX)
- -> reversible after tx stopped
- -> can use normal HF tx (eg. B-blocker, ACEI)
- -> if get symptomatic HF, must d/c trastuzumab
MC form of breast cancer
Invasive ductal CA
Tx for Invasive Breast Cancer
Lumpectomy + radiation (breast conserving therapy)
When is modified radical mastectomy (NOT breast conserving) the answer?
If pt pregnant Diffuse malignancy OR ≥ 2 sites in separate quadrants Tumor > 5cm Positive tumor margins Prior irradiation to breast